4//SEC Filing
Miller Andrew Craig 4
Accession 0001593968-23-000302
CIK 0001771917other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:33 PM ET
Size
7.0 KB
Accession
0001593968-23-000302
Insider Transaction Report
Form 4
Miller Andrew Craig
Chief Operating Officer
Transactions
- Award
Common Stock
2023-02-09+12,550→ 30,900 total - Award
Option (right to buy)
2023-02-09+25,100→ 25,100 totalExercise: $187.26Exp: 2033-02-08→ Common Stock (25,100 underlying)
Footnotes (2)
- [F1]Comprised of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest annually in four 25% installments commencing on February 9, 2024, subject to continued service through such dates.
- [F2]25% of this option shall vest on February 9, 2024, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.
Documents
Issuer
Karuna Therapeutics, Inc.
CIK 0001771917
Entity typeother
Related Parties
1- filerCIK 0001777760
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:33 PM ET
- Size
- 7.0 KB